MRO Magazine

News

Rapid-turnaround program announced for occupational safety testing for chemical and pharmaceutical manufacturers

Gaithersburg, Md. -- Bridge Pharmaceuticals Inc. has begun to offer a new service for obtaining occupational safety...


Gaithersburg, Md. — Bridge Pharmaceuticals Inc. has begun to offer a new service for obtaining occupational safety studies on compound exposure during chemical manufacture and handling. With faster study turnarounds and flexible data reporting, Bridge will make it easier for companies to guard their employees against chemical exposure hazards.

Before a new compound can be manufactured, regulators require toxicology studies to judge the risks of acute exposure (i.e., exposure lasting a few minutes to a few days) to the new compound. Testing guidelines are set by the U.S. Federal Hazardous Substances Act (FHSA), Department of Transportation, and Environmental Protection Agency, the European Unions Organization for Economic Co-Operation and Development (OECD), and the Ministry of Agriculture, Forestries, and Fisheries (MAFF) in Japan. Because of the complexity of these tests and their guidelines, occupational safety chemical exposure studies often take four weeks.

At Bridges U.S. facility in Gaithersburg, studies performed as non-GLP or fully GLP compliant will have turnarounds no longer than three weeks. Chemical, pharmaceutical and biotech companies need occupational safety studies for thousands of compounds each year. With so many compounds to evaluate, placing studies with Bridge for whole series of compounds will mean major time savings without compromising safety.

Bridge also says it will make its test results easier to interpret. By combining faster studies with more convenient reporting formats, Bridges new Occupational Safety Program will help companies minimize compound-related occupational safety hazards more quickly and easily.

Bridge is one of the first preclinical contract research organization (CRO) to provide US-level drug development services in both the US and Asia. For more information, visit www.bridgecro.com or contact info@bridgecro.com.